Rosiglitazone and cardiovascular disease: a diabetologist's perspective
Diab Vasc Dis Res 2007 4: 75-76. [PDF] [References] [Request Permission]  

Rosiglitazone and cardiovascular disease: an epidemiologist's perspective
Diab Vasc Dis Res 2007 4: 77-79. [PDF] [References] [Request Permission]  

Rosiglitazone and cardiovascular disease: a cardiologist's perspective
Diab Vasc Dis Res 2007 4: 80-81. [PDF] [References] [Request Permission]  

Nikolaus Marx and Peter J Grant

Endothelial dysfunction and cardiovascular disease - the lull before the storm
Diab Vasc Dis Res 2007 4: 82-83. [PDF] [References] [Request Permission]  

Martin M Hartge, Thomas Unger, and Ulrich Kintscher

The endothelium and vascular inflammation in diabetes
Diab Vasc Dis Res 2007 4: 84-88. [Abstract] [PDF] [References] [Request Permission]  

Sandra J Hamilton, Gerard T Chew, and Gerald F Watts

Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus
Diab Vasc Dis Res 2007 4: 89-102. [Abstract] [PDF] [References] [Request Permission]  

Richard M Cubbon, Adil Rajwani, and Stephen B Wheatcroft

The impact of insulin resistance on endothelial function, progenitor cells and repair
Diab Vasc Dis Res 2007 4: 103-111. [Abstract] [PDF] [References] [Request Permission]  

Russell E Anderson, Kerstin Brismar, and Torbjörn Ivert

Only a minority of patients referred for elective coronary artery bypass surgery have risk factors diagnosed and treated according to established guidelines
Diab Vasc Dis Res 2007 4: 112-116. [Abstract] [PDF] [References] [Request Permission]  

Charles W Bolten, Maria A Payne, William G McDonald, Patrick M Blanner, Robert C Chott, Sarbani Ghosh, Graciela B Arhancet, Nicholas R Staten, Eric A Gulve, Patrick M Sullivan, Alexander E Hromockyj, and Jerry R Colca

Thiazolidinediones inhibit the progression of established hypertension in the Dahl salt-sensitive rat
Diab Vasc Dis Res 2007 4: 117-123. [Abstract] [PDF] [References] [Request Permission]  

Puneetpal Singh, Monica Singh, Sunil Gaur, and Taranpal Kaur

The ApoAI-CIII-AIV gene cluster and its relation to lipid levels in type 2 diabetes mellitus and coronary heart disease: determination of a novel susceptible haplotype
Diab Vasc Dis Res 2007 4: 124-129. [Abstract] [PDF] [References] [Request Permission]  

Giovanni La Montagna, Federico Cacciapuoti, Rosario Buono, Daniela Manzella, Gianna Angela Mennillo, Alessandro Arciello, Gabriele Valentini, and Giuseppe Paolisso

Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis
Diab Vasc Dis Res 2007 4: 130-135. [Abstract] [PDF] [References] [Request Permission]  

Eberhard Windler, Mark Schöffauer, and Birgit-Christiane Zyriax

The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular disease
Diab Vasc Dis Res 2007 4: 136-142. [Abstract] [PDF] [References] [Request Permission]  

Anthony S Wierzbicki

Homocysteine and cardiovascular disease: a review of the evidence
Diab Vasc Dis Res 2007 4: 143-149. [Abstract] [PDF] [References] [Request Permission]  

Peter R Flatt

Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs?
Diab Vasc Dis Res 2007 4: 150-152. [Abstract] [PDF] [References] [Request Permission]  

Vicky L Benson, Aisling C McMahon, Harry C Lowe, Levon M Khachigian, and Harry C Lowe

The streptozotocin-treated Sprague-Dawley rat: a useful model for the assessment of acute and chronic effects of myocardial ischaemia reperfusion injury in experimental diabetes
Diab Vasc Dis Res 2007 4: 153-154. [PDF] [References] [Request Permission]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.